CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • COVID-19 and Cancer Vaccines with Immunotherapy Pioneers Ugur Sahin and Özlem Türeci

    Ugur Sahin and Ozlem Tureci, two of this year’s CRI Coley Award recipients, are pioneers of the…

    December 21, 2021| Arthur N. Brodsky, PhD
  • COVID-19’s Impact on Oncology Clinical Trials: A One-Year Follow-Up Analysis

    A new CRI report highlights the impact of the COVID-19 pandemic on cancer clinical trials compared to…

    May 17, 2021| Robert Levine
  • What to Expect in Cancer Immunotherapy in 2021: COVID-19, Biomarkers, and Clinical Trial Design

    Dr. Kunle Odunsi shares his thoughts on what lies ahead for the field of cancer immunotherapy.

    April 6, 2021| Arthur N. Brodsky, PhD
  • Charting the Course Ahead: CRI’s CEO Weighs in on 2020 and the Bright Path Forward

    CRI CEO Jill O’Donnell-Tormey, PhD, on how the organization as well as cancer research and treatment are…

    March 9, 2021| Brian Brewer
  • Cancer, COVID-19, and Vaccines: What Patients Need to Know

    CRI experts share their latest insights on COVID-19 and cancer.

    February 5, 2021| Arthur N. Brodsky, PhD
  • How Cancer Immunotherapy is Helping Speed a COVID-19 Vaccine

    CRI Fellow Susan Klaeger, PhD, is optimizing a method to identify which antigens make the best targets…

    November 17, 2020| Arthur N. Brodsky, PhD
  • CRI Scientific Leadership in Cancer and COVID-19

    Members of the CRI Scientific Advisory Council are providing their immunology expertise and sharing lessons from cancer…

    August 28, 2020| Alice Northover
  • Stellar Science Solving Cancer and COVID-19

    CRI Lloyd J. Old STARs are contributing to immunology work to combat COVID-19.

    August 27, 2020| Alice Northover
  • Medical Technology to Fight Cancer and COVID-19

    CRI Technology Impact Award recipients are adapting technologies developed for cancer immunotherapies to understand and treat COVID-19….

    August 26, 2020| Alice Northover
1 2 3
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute